These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22078645)

  • 21. Present and potential future issues in glioblastoma treatment.
    Lefranc F; Sadeghi N; Camby I; Metens T; Dewitte O; Kiss R
    Expert Rev Anticancer Ther; 2006 May; 6(5):719-32. PubMed ID: 16759163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival comparison between glioblastoma multiforme and other incurable cancers.
    Tran B; Rosenthal MA
    J Clin Neurosci; 2010 Apr; 17(4):417-21. PubMed ID: 20167494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Designer therapies for glioblastoma multiforme.
    Sathornsumetee S; Rich JN
    Ann N Y Acad Sci; 2008 Oct; 1142():108-32. PubMed ID: 18990124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary.
    Jarzabek MA; Sweeney KJ; Evans RL; Jacobs AH; Stupp R; O'Brien D; Berger MS; Prehn JH; Byrne AT
    Drug Discov Today; 2013 Nov; 18(21-22):1052-66. PubMed ID: 23792334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
    Chang JE; Khuntia D; Robins HI; Mehta MP
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):894-902, 907-15. PubMed ID: 18185489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treating recurrent glioblastoma: an update.
    Kamiya-Matsuoka C; Gilbert MR
    CNS Oncol; 2015; 4(2):91-104. PubMed ID: 25768333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current status and prospect in the treatment of glioblastoma].
    Jiang HH; Lin S
    Zhonghua Wai Ke Za Zhi; 2020 Jan; 58(1):70-74. PubMed ID: 31902174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic options for recurrent high-grade glioma in adult patients: recent advances.
    Nieder C; Adam M; Molls M; Grosu AL
    Crit Rev Oncol Hematol; 2006 Dec; 60(3):181-93. PubMed ID: 16875833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New therapeutic options in therapy of glioblastoma multiforme].
    Lakomý R; Burkon P; Burkonová D; Jancálek R
    Klin Onkol; 2010; 23(6):381-7. PubMed ID: 21351415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glioblastoma multiforme: evidence-based approach to therapy.
    Nicholas MK
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S23-7. PubMed ID: 18076314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glioblastoma therapy: going beyond Hercules Columns.
    Mangiola A; Anile C; Pompucci A; Capone G; Rigante L; De Bonis P
    Expert Rev Neurother; 2010 Apr; 10(4):507-14. PubMed ID: 20367204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.
    Simpson L; Galanis E
    Expert Rev Anticancer Ther; 2006 Nov; 6(11):1593-607. PubMed ID: 17134364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NovoTTF-100A: a new treatment modality for recurrent glioblastoma.
    Fonkem E; Wong ET
    Expert Rev Neurother; 2012 Aug; 12(8):895-9. PubMed ID: 22708931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trials for glioblastoma multiforme using adenoviral vectors.
    Wirth T; Samaranayake H; Pikkarainen J; Määttä AM; Ylä-Herttuala S
    Curr Opin Mol Ther; 2009 Oct; 11(5):485-92. PubMed ID: 19806496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New therapeutic approaches in glioblastomas].
    Le Guilloux J; Carpentier AF
    Rev Neurol (Paris); 2008; 164(6-7):554-9. PubMed ID: 18565354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Present and Future of Anti-Glioblastoma Therapies: A Deep Look into Molecular Dependencies/Features.
    Kim HJ; Kim DY
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33053763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and treatment of recurrent high-grade astrocytoma.
    Butowski NA; Sneed PK; Chang SM
    J Clin Oncol; 2006 Mar; 24(8):1273-80. PubMed ID: 16525182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progress in the study of brain tumor stem cells as treatment targets].
    Hide T; Kuratsu J
    Brain Nerve; 2009 Jul; 61(7):781-9. PubMed ID: 19618855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glioblastoma: Overview of Disease and Treatment.
    Davis ME
    Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S2-8. PubMed ID: 27668386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.